Latest H&Q Healthcare Investors (HQH) Headlines
Post# of 2
Posted On: 03/14/2014 12:53:36 AM
Latest H&Q Healthcare Investors (HQH) Headlines
H&Q Healthcare Investors Authorizes a Rights Offering
Business Wire - Wed Mar 12, 8:08AM CDT
On March 12, 2014, the Board of Trustees of H&Q Healthcare Investors (the "Fund") authorized the filing of a preliminary registration statement with the Securities and Exchange Commission for a proposed rights offering by the Fund to its shareholders to acquire additional shares (the "Offering"). Key aspects of the Offering, including the timing and the pricing, have yet to be determined. The Board reserves the right to delay or cancel the Offering.
Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: HQH, ASBC, L
at The Street - Wed Feb 26, 9:00AM CST
HQH ASBC L are going ex-dividend tomorrow, Thursday, Feb. 27, 2014, 5:00 AM ET
H&Q Healthcare Investors Declares Stock Distribution
Business Wire - Thu Feb 20, 10:01AM CST
On February 20, 2014, H&Q Healthcare Investors declared a stock distribution of $0.53 per share. The record date for the stock distribution is March 3, 2014 and the payable date is March 31, 2014. The Fund will trade ex-distribution on February 27, 2014.
Shares of HQH Up 14.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 23, 11:10AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 28th, 2013 at $24.51. In approximately 3 months, H&Q Healthcare Investors has returned 14.81% as of today's recent price of $28.14.
H&Q Healthcare Investors Pays Stock Distribution
Business Wire - Thu Jan 02, 10:54AM CST
On December 31, 2013, H&Q Healthcare Investors paid a quarterly stock distribution of $0.50 per share. It is estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on the sale of securities is $296,454,467, of which $290,000,464 represents net unrealized appreciation of portfolio securities.
Ex-Dividend Alert: 5 Stocks Going Ex-Dividend Monday: HQH, B, LPS, MAT, VLO
at The Street - Fri Nov 22, 9:00AM CST
HQH B LPS MAT VLO are going ex-dividend Monday, Nov. 25, 2013
H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Investor Information Seminar
Business Wire - Tue Jun 04, 12:59PM CDT
H&Q Healthcare Investors and H&Q Life Sciences Investors invite you to attend or participate via webcast an Investor Information Seminar on Friday, June 7, 2013, at 8:30 a.m. The Seminar will be held at the Downtown Club of Boston, 38th Floor, Boston, Massachusetts.
CORRECTING and REPLACING H&Q Healthcare Investors Declares Stock Distribution
Business Wire - Wed May 22, 12:31PM CDT
First graph, third sentence of release dated May 17, 2013 should read: The Fund will trade ex-distribution on May 23, 2013. (sted The Fund will trade ex-distribution on May 24, 2013.)
H&Q Healthcare Investors Announces Renewal of Share Repurchase Program
Business Wire - Fri Mar 22, 1:07PM CDT
H&Q Healthcare Investors (NYSE: HQH) (the "Fund") announced today that the Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 10, 2013. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year period ending July 10, 2014. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the net asset value per share. The share repurchase program is intended to increase the Fund's net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.
CardioKinetix Completes $48 Million in Series E Financing for Catheter-Based Heart Failure Therapy
Business Wire - Thu Feb 28, 6:00AM CST
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has completed the $23 million second-tranche of its Series E financing, bringing the total financing round to $48 million. Panorama Capital has newly joined the Company's investor group of U.S. Venture Partners, JPMorgan Partners, New Leaf Venture Partners, SV Life Sciences, H&Q Healthcare Investors (NYSE: HQH), and H&Q Life Sciences Investors (NYSE: HQL).
WEALTHMAKERS.COM Issues Bullish Research Reports on ARO, ASI, BDR, EEFT, HQH, ICLR
M2 - Fri Feb 22, 2:29AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Aeropostale Inc (NYSE:ARO), American Safety Insurance Holdings Ltd (NYSE:ASI), Blonder Tongue Laboratories Inc (AMEX:BDR), Euronet Worldwide Inc (NASDAQ:EEFT), H & Q Healthcare Investors (NYSE:HQH), ICON PLC (NASDAQ:ICLR)
Labcyte Inc. Closes $5.3 Million Financing
Business Wire - Tue Jan 08, 12:09PM CST
Labcyte Inc., a privately-held company advancing acoustic liquid handling, today announced it has closed a Series D financing led by the healthymagination fund, a part of GE Ventures. The $5.3 million round also included current Labcyte investors: Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, H&Q Healthcare Investors (NYSE:HQH) and H&Q Life Sciences Investors (NYSE:HQL).
H&Q Healthcare Investors Authorizes a Rights Offering
Business Wire - Wed Mar 12, 8:08AM CDT
On March 12, 2014, the Board of Trustees of H&Q Healthcare Investors (the "Fund") authorized the filing of a preliminary registration statement with the Securities and Exchange Commission for a proposed rights offering by the Fund to its shareholders to acquire additional shares (the "Offering"). Key aspects of the Offering, including the timing and the pricing, have yet to be determined. The Board reserves the right to delay or cancel the Offering.
Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: HQH, ASBC, L
at The Street - Wed Feb 26, 9:00AM CST
HQH ASBC L are going ex-dividend tomorrow, Thursday, Feb. 27, 2014, 5:00 AM ET
H&Q Healthcare Investors Declares Stock Distribution
Business Wire - Thu Feb 20, 10:01AM CST
On February 20, 2014, H&Q Healthcare Investors declared a stock distribution of $0.53 per share. The record date for the stock distribution is March 3, 2014 and the payable date is March 31, 2014. The Fund will trade ex-distribution on February 27, 2014.
Shares of HQH Up 14.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 23, 11:10AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 28th, 2013 at $24.51. In approximately 3 months, H&Q Healthcare Investors has returned 14.81% as of today's recent price of $28.14.
H&Q Healthcare Investors Pays Stock Distribution
Business Wire - Thu Jan 02, 10:54AM CST
On December 31, 2013, H&Q Healthcare Investors paid a quarterly stock distribution of $0.50 per share. It is estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on the sale of securities is $296,454,467, of which $290,000,464 represents net unrealized appreciation of portfolio securities.
Ex-Dividend Alert: 5 Stocks Going Ex-Dividend Monday: HQH, B, LPS, MAT, VLO
at The Street - Fri Nov 22, 9:00AM CST
HQH B LPS MAT VLO are going ex-dividend Monday, Nov. 25, 2013
H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Investor Information Seminar
Business Wire - Tue Jun 04, 12:59PM CDT
H&Q Healthcare Investors and H&Q Life Sciences Investors invite you to attend or participate via webcast an Investor Information Seminar on Friday, June 7, 2013, at 8:30 a.m. The Seminar will be held at the Downtown Club of Boston, 38th Floor, Boston, Massachusetts.
CORRECTING and REPLACING H&Q Healthcare Investors Declares Stock Distribution
Business Wire - Wed May 22, 12:31PM CDT
First graph, third sentence of release dated May 17, 2013 should read: The Fund will trade ex-distribution on May 23, 2013. (sted The Fund will trade ex-distribution on May 24, 2013.)
H&Q Healthcare Investors Announces Renewal of Share Repurchase Program
Business Wire - Fri Mar 22, 1:07PM CDT
H&Q Healthcare Investors (NYSE: HQH) (the "Fund") announced today that the Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 10, 2013. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year period ending July 10, 2014. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the net asset value per share. The share repurchase program is intended to increase the Fund's net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.
CardioKinetix Completes $48 Million in Series E Financing for Catheter-Based Heart Failure Therapy
Business Wire - Thu Feb 28, 6:00AM CST
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has completed the $23 million second-tranche of its Series E financing, bringing the total financing round to $48 million. Panorama Capital has newly joined the Company's investor group of U.S. Venture Partners, JPMorgan Partners, New Leaf Venture Partners, SV Life Sciences, H&Q Healthcare Investors (NYSE: HQH), and H&Q Life Sciences Investors (NYSE: HQL).
WEALTHMAKERS.COM Issues Bullish Research Reports on ARO, ASI, BDR, EEFT, HQH, ICLR
M2 - Fri Feb 22, 2:29AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Aeropostale Inc (NYSE:ARO), American Safety Insurance Holdings Ltd (NYSE:ASI), Blonder Tongue Laboratories Inc (AMEX:BDR), Euronet Worldwide Inc (NASDAQ:EEFT), H & Q Healthcare Investors (NYSE:HQH), ICON PLC (NASDAQ:ICLR)
Labcyte Inc. Closes $5.3 Million Financing
Business Wire - Tue Jan 08, 12:09PM CST
Labcyte Inc., a privately-held company advancing acoustic liquid handling, today announced it has closed a Series D financing led by the healthymagination fund, a part of GE Ventures. The $5.3 million round also included current Labcyte investors: Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, H&Q Healthcare Investors (NYSE:HQH) and H&Q Life Sciences Investors (NYSE:HQL).
(0)
(0)H&Q Healthcare Investors (HQH) Stock Research Links
Scroll down for more posts ▼